You are fixated solely on today's price and not seeing past tomorrow. Leo is not on a train schedule, drugs especially very complicated drugs are extremely difficult to develop and bring to market for any pharma let alone a micro-cap. We now have a definitive human study that proves B works and K looks very promising. I for one was invested in a small otc working on pancreatic cancer therapy, after many years still no expanded studies pps remains in the pennies. Otc bio pharmaceuticals are a crap shoot, sage investors in the field have a better chance of seeing through the company propaganda.
News 
Market Data 
Discover 
